Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.43%, DAX30 +0.18%, CAC40 +0.05%

Aug 27 ,2024

  • Synopsis

    • European equity markets indicated to open higher, whilst Asian equities are lower Tuesday. Regional benchmarks logging mild declines with growth/tech/semis underperforming. Hong Kong-listed consumer shares under pressure following Temu-owner PDD's downbeat outlook. S&P 500 futures flat afterhours. Oil prices steady following Monday rally on Middle East tensions and Libyan output cut.

    • On today's agenda, EU's Ferreira speech at ERSA conf whilst Spain's PM Sánchez visits Mauritania, Senegal and Gambia to discuss migration and aid (through Thu). UK PM Starmer keynote speech. In central banks, Hungary interest rate decision and Norges Bank's Gerdrup speech at 10:00CET. Bundesbank's Nagel in discussion at 16:00CET (livestream) and Netherlands Central Bank's Knot speaks at 12:45CET at EEA-ESEM (Mon-Fri).

    • September Fed rate cut widely expected debate has pivoted to whether it will be 25 bp or 50 bp move. Odds of 50 bp cut stand at ~30% as markets continue to price in ~100 bp of easing in final three meetings of the year. That has increased importance of August US payrolls (6-Sep) in shaping 25 vs 50 bp debate as Fed policy focus shifts more to preventing harder labor market slowdown.

    • Near-term focus is on NVDA's earnings, to be released after US market close on Wednesday. Expectations are high with markets anticipating another beat and raise. Options market positioning suggesting share price moves of 9-10% in either direction following the results with potential for swings in shares of Asian semis

    • In light corporate news flow, out of DACHs, Dermapharm Holding (DMP.GR), Sonova Holding (SOON.SW), Vaudoise Assurances Holding (VAHN.SW), and Flughafen Zuerich (FHZN.SW) are amongst other in the region to update investors with their latest numbers. In Benelux, Greenyard (GREEN.BB) reported strong Q1 revenue. Also, BHP Group (BHP.LN) reported FY earnings with results mostly in line with expectations and confirmed FY guidance.

  • Politics/Macro/World News

    • Rise of active ETFs highlights looming prospect of dwindling fees - FT

    • PM to say Parliament return not 'business as usual' - BBC

    • UK Banks Brace for a Lending Boom on Labour's Housebuilding Goals - Bloomberg

    • Chaos in France after Macron refuses to name prime minister from leftwing coalition - The Guardian

    • Wall Street Sours On Oil as Goldman Flags Risks From OPEC+ Boost - Bloomberg

  • Top company news

    • Earnings/updates

      • BHP.LN (BHP Group) -- reports FY EPS $2.70 vs FactSet $2.70 [23 est, $2.44-3.11]

      • DACHs

        • SOON.SW (Sonova Holding) -- reaffirms FY24/25 outlook - CMD

        • MOLN.SW (Molecular Partners) -- reports H1 EPS (CHF0.80) vs year-ago (CHF0.94)

        • ACLN.SW (Accelleron Industries) -- reports H1 EPS $0.90 vs FactSet $0.87 [1 est]; reaffirms FY guidance

        • TXGN.SW (TX Group) -- reports H1 adjusted net income CHF48.4M vs year-ago CHF46.4M

        • ARBN.SW (Arbonia) -- reports H1 net income CHF40.9M vs FactSet CHF0M

        • FHZN.SW (Flughafen Zuerich) -- reports H1 net income CHF151.8M vs FactSet CHF162.2M; expects a larger consolidated profit for FY24 vs year-ago

        • BRNK.GR (Branicks Group) -- confirms previously reported H1 FFO €0.24 vs year-ago €0.36

        • VAHN.SW (Vaudoise Assurances Holding) -- reports H1 net income CHF81.2M, +16% vs year-ago CHF70.0M

        • DMP.GR (Dermapharm Holding) -- confirms prelim. H1 results; reiterates 2024 outlook

      • Benelux

        • GREEN.BB (Greenyard) -- reports Q1 revenue €1.34B, +4% vs year-ago €1.28B

        • UPG.BB (Unifiedpost Group) -- reports H1 net income cont ops (€24.4M) vs year-ago (€24.0M)

      • Nordics

        • BOUV.NO (Bouvet)-- reports Q2 EPS NOK1.00 vs FactSet NOK0.94

        • SMCRT.NO (SmartCraft) -- reports Q2 net income NOK27.0M vs FactSet NOK31.2M

        • RANA.NO (Rana Gruber) -- reports Q2 adjusted net income NOK137.4M ex-items vs FactSet NOK178.2M

        • CAPSL.NO (Capsol Technologies) -- reports Q2 EPS (NOK0.35) vs FactSet (NOK0.17)

        • WSTEP.NO (Webstep) -- reports Q2 EPS NOK0.50 vs FactSet NOK0.52

      • Also due to report today:

        • Earnings:

          • DACHs: PIERER Mobility (PKTM.SW)

          • Nordics: LE Lundbergforetagen (LUND.B.SS), SyntheticMR (SYNT.SS), Concejo (CNCJO.B.SS), MasOval (MAS.NO), Nordic Mining (NOM.NO), Green Hydrogen Systems (GREENH.DC)

          • UK: Bunzl (BNZL.LN), Faron Pharmaceuticals (FARN.LN)

        • Trading Update: Greenyard (GREEN.BB)

        • Traffic: VINCI (DG.FP)

    • M&A

      • SRS.IM (Saras) -- Varas increases stake in Saras to 90.1%

      • STF.FP (Stef) -- subsidiary Langdons announces the acquisition of the transport and logistics group Long Lane Deliveries in Scotland

      • UPG.BB (Unifiedpost Group) -- to sell Wholesale Identity Access business in the Netherlands to Your.World for base purchase price based on EV of €133M

      • MOBA.NO (Morrow Bank) -- ASA receives approval from Danish FSA to acquire Lunar Bank´s Swedish consumer loan portfolio

      • HOCN.SW (HOCHDORF Holding) -- agrees to sell HOCHDORF Swiss Nutrition Ltd to AS Equity Partners for CHF83M (enterprise value); To propose delisting of the company's shares

      • Speculation around possibility of further M&A activity amongst oil and gas players in the Perth Basin - The Australian

      • VOLUE.NO (Volue) -- board unanimously decides to advise the Company's shareholders to accept the NOK42/share offer from Edison Bidco

    • Healthcare

      • ROG.SW (Roche Holding) -- Roche's Piasky has been approved by the European Commission as the first monthly subcutaneous treatment for people with PNH

      • ALCLS.FP (Cellectis SA) -- publishes a Molecular Therapy article on a SMART DUAL CAR T-cell approach for treating recalcitrant solid tumors

      • ADXN.SW (Addex Therapeutics) -- and Indivior announce selection of clinical candidates from their GABAB positive allosteric modulator (PAM) research collaboration

    • Other

      • TIGO.SS (Millicom International Cellular) -- SEC filing: SC 13D/A (Filed by Atlas Investissement)

      • FGR.FP (Eiffage) -- led consortium wins contract worth close to €700M to build an office complex

      • AGL Energy and Neoen sign second virtual battery agreement

      • Toyota, BMW to upgrade partnership in fuel-cell vehicles - Nikkei

  • Key rating changes

    • Upgrades

      • CON.GR (Continental) -- to buy from neutral at UBS

      • GL9.ID (Glanbia) -- to buy from hold at Kepler Cheuvreux

    • Downgrades

      • SCHP.SW (Schindler Holding) -- to sell from neutral at Goldman Sachs

      • ABF.LN (Associated British Foods) -- to sell from hold at Deutsche Numis

      • DTG.GR (Daimler Truck Holding) -- to neutral from buy at Goldman Sachs

    • Other Actions

      • BDEV.LN (Barratt Developments) -- resumed equal-weight at Morgan Stanley

  • Data

    • Nikkei +0.36% to 38247.17

    • Hang Seng (0.04%) to 17792.19

    • Shanghai Composite (0.32%) to 2846.39

    • S&P futures (0.3) vs prior close of 5637.0

    • €-$ +0.0006 or +0.05% to 1.1166

    • $-¥ +0.26 or +0.18% to 144.82

    • €-¥ +0.39 or +0.24% to 161.70

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE